日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study

非GABA类睡眠药物和舒沃雷生作为跌倒风险因素：病例对照和病例交叉研究

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0238723
Ishibashi, Yoshiki; Nishitani, Rie; Shimura, Akiyoshi; Takeuchi, Ayano; Touko, Mamoru; Kato, Takashi; Chiba, Sahoko; Ashidate, Keiko; Ishiwata, Nobuo; Ichijo, Tomoyasu; Sasabe, Masataka
发表日期：2020
文献求助 收藏

Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects

依折麦布附加治疗对 2 型糖尿病患者 52 周疗效的前瞻性随机试验（RESEARCH 研究）扩展分析

期刊:Lipids in Health and Disease
影响因子:4.2
doi:10.1186/s12944-017-0508-4
Sakamoto, Kentaro; Kawamura, Mitsunobu; Watanabe, Takayuki; Ashidate, Keiko; Kohro, Takahide; Tanaka, Akira; Mori, Yasumichi; Tagami, Motoki; Hirano, Tsutomu; Yamazaki, Tsutomu; Shiba, Teruo
糖尿病
ARC
代谢
发表日期：2017
文献求助 收藏

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins

依泽替米贝对服用他汀类药物控制不佳的2型糖尿病患者低密度脂蛋白胆固醇降低及致动脉粥样硬化脂蛋白谱的影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0138332
Sakamoto, Kentaro; Kawamura, Mitsunobu; Kohro, Takahide; Omura, Masao; Watanabe, Takayuki; Ashidate, Keiko; Horiuchi, Toshiyuki; Hara, Hidehiko; Sekine, Nobuo; Chin, Rina; Tsujino, Motoyoshi; Hiyoshi, Toru; Tagami, Motoki; Tanaka, Akira; Mori, Yasumichi; Inazawa, Takeshi; Hirano, Tsutomu; Yamazaki, Tsutomu; Shiba, Teruo
糖尿病
心血管
动脉粥样硬化
代谢
发表日期：2015
文献求助 收藏